Výsledky vyhledávání - "Cale D. Fahrenholtz"

Akademický článek

Enhancement of Triple-Negative Breast Cancer-Specific Induction of Cell Death by Silver Nanoparticles by Combined Treatment with Proteotoxic Stress Response Inhibitors

Autor: Christina M. Snyder, Beatriz Mateo, Khushbu Patel, Cale D. Fahrenholtz, Monica M. Rohde, Richard Carpenter, Ravi N. Singh

Publikováno v: Nanomaterials, Vol 14, Iss 19, p 1564 (2024)

Metal nanoparticles have been tested for therapeutic and imaging applications in pre-clinical models of cancer, but fears of toxicity have limited their translation. An emerging concept in nanomedicine is to exploit the inherent drug-like properties

Externí odkaz: https://doaj.org/article/8c5ededc80444ec19eee27a4b903f4af

Zobrazit plný text záznamu

Akademický článek

Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Plexiform Neurofibroma Cells at Doses That Do Not Affect Patient-Matched Schwann Cells

Autor: Bashnona Attiah, Garrett Alewine, Mary-Kate Easter, Robert A. Coover, Cale D. Fahrenholtz

Publikováno v: Pharmaceutics, Vol 16, Iss 3, p 371 (2024)

Neurofibromatosis Type 1 (NF1) is a common neurogenic condition characterized by heterozygous loss of function mutations in the neurofibromin gene. NF1 patients are susceptible to the development of neurofibromas, including plexiform neurofibromas (p

Externí odkaz: https://doaj.org/article/4c8e457f923f41c38b1827e9a7fcd4a3

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Silver nanoparticles selectively treat triple‐negative breast cancer cells without affecting non‐malignant breast epithelial cells in vitro and in vivo

Autor: Jessica Swanner, Cale D. Fahrenholtz, Iliana Tenvooren, Brian W. Bernish, James J. Sears, Allison Hooker, Cristina M. Furdui, Elizabeth Alli, Wencheng Li, George L. Donati, Katherine L. Cook, Pierre‐Alexandre Vidi, Ravi Singh

Publikováno v: FASEB BioAdvances, Vol 1, Iss 10, Pp 639-660 (2019)

Abstract Silver nanoparticles (AgNPs) show promise for treatment of aggressive cancers including triple‐negative breast cancer (TNBC) in preclinical cancer models. For clinical development of AgNP‐based therapeutics, it will be necessary to clear

Externí odkaz: https://doaj.org/article/08194cb37e6d42569e52b2e97a9fcfdd

Zobrazit plný text záznamu

Silver nanoparticles selectively treat triple‐negative breast cancer cells without affecting non‐malignant breast epithelial cells in vitro and in vivo

Autor: George L. Donati, Pierre-Alexandre Vidi, Katherine L. Cook, Allison Hooker, Iliana Tenvooren, Ravi Singh, Wencheng Li, Cristina M. Furdui, Brian W. Bernish, Jessica Swanner, Elizabeth Alli, Cale D. Fahrenholtz, James Sears

Publikováno v: FASEB BioAdvances, Vol 1, Iss 10, Pp 639-660 (2019)
FASEB bioAdvances

Silver nanoparticles (AgNPs) show promise for treatment of aggressive cancers including triple‐negative breast cancer (TNBC) in preclinical cancer models. For clinical development of AgNP‐based therapeutics, it will be necessary to clearly define

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10cbdcf0fe3c8b35c82a3456d0a07b8c
https://doaj.org/article/08194cb37e6d42569e52b2e97a9fcfdd

Zobrazit plný text záznamu

Abstract 373: Silver nanoparticles are selectively cytotoxic to neurofibromin 1 deficient peripheral nerve sheath tumors

Autor: Garrett Alewine, Adithya Ghantae, Christina Mamrega, Jerrica L. Knight, Bashnona Attiah, Robert A. Coover, Cale D. Fahrenholtz

Publikováno v: Cancer Research. 82:373-373

Neurofibromatosis type 1 (NF1) is the most common neurogenic disorder affecting 1 in every 3,000 people worldwide. NF1 is defined by heterozygous loss-of-function of the neurofibromin 1 gene (NF1). NF1 patients develop neurofibromas with near complet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cb18e84e0939293091264c94f0451a1b
https://doi.org/10.1158/1538-7445.am2022-373

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání